Skip to content

Member

Raphaël GLUCKSMANN

S&D · France

Group
S&D
Country
France
Roll-call participation
87.4 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
94.6 %ⓘ of 542 votes where the group had a line · S&D median 97.1 %
More facts (5)
National party
Place publique
In office
Since 16 Jul 2024
Against clear line
26 of 535 votesⓘ
Committees
AFET (substitute), INTA (substitute), SEDE
Member id
197694
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

87.4 %

542 of 620 final votes while in office

S&D median: 89.5 % (−2.1 pts)

Chamber median: 90.6 %

With majority line ⓘ

94.6 %

513 of 542 votes where their group had a line

S&D median: 97.1 % (−2.5 pts)

Against clear line ⓘ

4.9 %

26 of 535 votes where their group had a clear line

12 opposite (for ↔ against), 14 abstained against the line

Abstention ⓘ

3.5 %

19 of 542 votes cast

Participation 87.4 % — S&D median 89.5 %, 137 members.ⓘ
Data as a table
Participation among the 137 members of the S&D with enough votes.
FigureParticipation
Raphaël GLUCKSMANN87.4 %
S&D median89.5 %
Lowest in the group48.1 %
Highest in the group99.8 %
Members137
With majority line 94.6 % — S&D median 97.1 %, 137 members.ⓘ
Data as a table
With majority line among the 137 members of the S&D with enough votes.
FigureWith majority line
Raphaël GLUCKSMANN94.6 %
S&D median97.1 %
Lowest in the group86.7 %
Highest in the group99.8 %
Members137
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: No vote recorded Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: Abstained Majority line: Abstained
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: Abstained Majority line: Abstained
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: Against ≠ groupMajority line: Abstained
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 9 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Thomas PELLERIN-CARLIN S&DFrance99 % of 5 187 shared93 %
Aurore LALUCQ S&DFrance99 % of 4 422 shared93 %
Emma RAFOWICZ S&DFrance99 % of 3 881 shared93 %
Christophe CLERGEAU S&DFrance99 % of 4 557 shared93 %
Murielle LAURENT S&DFrance99 % of 4 902 shared93 %
Eric SARGIACOMO S&DFrance99 % of 4 967 shared93 %
Nora MEBAREK S&DFrance99 % of 4 820 shared93 %
Pierre JOUVET S&DFrance98 % of 4 599 shared93 %
Claire FITA S&DFrance98 % of 4 155 shared93 %
Chloé RIDEL S&DFrance98 % of 3 319 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Terry REINTKE GreensGermany88 % of 4 886 shared83 %
Veronika CIFROVÁ OSTRIHOŇOVÁ RenewSlovakia88 % of 4 134 shared86 %
Catarina VIEIRA GreensNetherlands88 % of 4 882 shared83 %
Kim VAN SPARRENTAK GreensNetherlands88 % of 4 858 shared83 %
Bas EICKHOUT Former memberGreensNetherlands88 % of 4 195 shared83 %
Anna CAVAZZINI GreensGermany88 % of 5 223 shared83 %
Erik MARQUARDT GreensGermany88 % of 5 000 shared83 %
Sara MATTHIEU GreensBelgium88 % of 4 546 shared83 %
Daniel FREUND GreensGermany88 % of 5 236 shared83 %
Kai TEGETHOFF GreensGermany88 % of 4 665 shared83 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Foreign AffairsAFET CommitteeSubstitute10 Mar 2026now
Committee on International TradeINTA CommitteeSubstitute15 Dec 2025now
Committee on Security and DefenceSEDE CommitteeMember23 Jan 2025now
Special Committee on the European Democracy ShieldEUDS Special committeeSubstitute23 Jan 2025now
Delegation to the EU-Ukraine Parliamentary Association CommitteeD-UA DelegationMember19 Sept 2024now
Delegation to the Euronest Parliamentary AssemblyDEPA Parliamentary assemblyMember19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Intergroup on LGBTIQ+IG10-16 Intergroup / working groupMember31 Jan 2025now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Intergroup on Seas, Rivers, Islands and Coastal Areas (SEARICA)IG10-20 Intergroup / working groupMember4 Feb 2025now

Show all 15 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
European Defence Industry Programme and a framework of measures to ensure the timely availability and supply of defence products (‘EDIP’)RapporteurSEDE14 Mar 2025
2021/0297(COD) Generalised scheme of tariff preferencesShadow rapporteurINTA20 Jan 2025
Rapporteur fictif permanent sur la RussieShadow rapporteurAFET15 Nov 2024
Rapporteur permanent pour le suivi des législations sur le travail forcé et le devoir de vigilanceRapporteurINTA15 Nov 2024
Proposition de règlement du Parlement européen et du Conseil relatif au filtrage des investissements étrangers dans l’Union et abrogeant le règlement (UE) 2019/452 du Parlement européen et du ConseilRapporteurINTA9 Nov 2024

Show all 5 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

46 contributions recorded; 5 on behalf of their group; 64 minutes of speaking time.

Show all 40 recent contributions

Questions and motions, 50

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
2 Sept 2026Protecting workers from extreme heatwaves E-10-2026-003456Written questionwith 8 co-authorsNot yet answered
15 Jul 2026Update by the Commission of its guidelines on tackling online disinformation during electoral processes E-10-2026-002950Written questionwith 31 co-authors11 Sept 2026
14 Jul 2026Preserving EU capacities to produce paper pulp and cellulose fibres – state of affairs at Fibre Excellence P-10-2026-002901Priority written questionwith 12 co-authors12 Aug 2026
8 Jul 2026Arbitrations under the Energy Charter Treaty brought against the EU by entities linked to sanctioned individuals E-10-2026-002842Written question17 Sept 2026
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
30 Jun 2026Follow-up to question for written answer E-001083/2025 on menstrual products: transparency and health risks E-10-2026-002698Written questionwith 43 co-authors18 Sept 2026
18 Jun 2026Human trafficking and human rights violations through recruitment of non-Russian nationals, in particular from Africa, for Russia’s war of aggression in Ukraine E-10-2026-002532Written questionwith 27 co-authors6 Aug 2026
17 Jun 2026Request that the Commission publish evidence pertaining to the non-activation of the Blocking Statute E-10-2026-002520Written questionwith 31 co-authorsNot yet answered
5 Jun 2026Alleged forced labour at the BYD construction site in Szeged, Hungary: follow-up E-10-2026-002325Written questionwith 2 co-authors22 Jul 2026
23 Apr 2026Risks hanging over the European steel industry and use of public funding by ArcelorMittal E-10-2026-001682Written questionwith 12 co-authors8 Jun 2026

Show all 50 questions and motions

Amendments tabled in committee, 64

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
22 Jul 2026The 28th regime corporate legal framework – 'EU Inc.' JURI-AM-791128 JURI4
22 Jul 2026The 28th regime corporate legal framework – ‘EU Inc.’ JURI-AM-791129 JURI1
5 Jun 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788898 ITRE1
18 May 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788892 ITRE3
18 May 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788896 ITRE16
18 May 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788895 ITRE2
18 May 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788902 ITRE10
18 May 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788897 ITRE1
18 May 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788849 ITRE1
18 May 2026Establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities ITRE-AM-788900 ITRE4

Show all 64 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation France National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
2 October 2026

Cite as

EU Parl Watch Research (2026). “Raphaël GLUCKSMANN”. Member record. memberId 197694. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197694?page=77&scope=final&vscope=all (retrieved 2 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197694. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197694?format=application%2Fld%2Bjson (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197694,
  author = {{EU Parl Watch Research}},
  title = {{Raphaël GLUCKSMANN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197694?page=77&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197694?page=77&scope=final&vscope=all},
  urldate = {2026-10-02},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197694. Official source: https://www.europarl.europa.eu/meps/en/197694. Data: EP Open Data: member record (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}